Ozempic has helped many make significant strides in their weight loss journey. The diabetes drug that also aids in weight loss works by activating GLP-1 receptors, which reduce hunger and control cravings.

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, and their potential downsides is key to making informed decisions.

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued weight loss. While well-tolerated, further long-term studies are needed to evaluate its safety and efficacy.

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist.

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being tested on children as young as six years old.

Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.